Nektar Therapeutics (NKTR) Finished Goods (2010 - 2024)

Nektar Therapeutics' Finished Goods history runs 13 years deep, the most recent figure standing at $2.2 million for Q2 2024.

• In Q2 2024, Finished Goods changed N/A year-over-year to $2.2 million; the TTM figure through Jun 2024 stood at $2.2 million (changed N/A YoY), while the FY2023 annual figure was $1.4 million, down 76.86% from the prior year.
• Finished Goods was $2.2 million for Q2 2024 at Nektar Therapeutics, down from $4.3 million in the prior quarter.
• In the past five years, Finished Goods ranged from a high of $5.9 million in Q4 2022 to a low of $921000.0 in Q3 2023.
• Historically, Finished Goods has averaged $2.9 million across 3 years, with a median of $2.2 million in 2024.
• Biggest YoY gain for Finished Goods was 76.86% in 2023; the steepest drop was 76.86% in 2023.
• A 3-year view of Finished Goods shows it stood at $5.9 million in 2022, then slumped by 76.86% to $1.4 million in 2023, then jumped by 58.53% to $2.2 million in 2024.
• The last three Finished Goods figures came in at $2.2 million (Q2 2024), $4.3 million (Q1 2024), and $1.4 million (Q4 2023), per Business Quant data.